Published in Cancer Res on June 23, 2009
Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer. Cancer Biol Ther (2009) 1.47
Evaluation of the anti-angiogenic properties of the new selective αVβ3 integrin antagonist RGDechiHCit. J Transl Med (2011) 0.99
Expressions of Osteopontin (OPN), ανβ3 and Pim-1 Associated with Poor Prognosis in Non-small Cell Lung Cancer (NSCLC). Chin J Cancer Res (2012) 0.92
Loss of zebrafish lgi1b leads to hydrocephalus and sensitization to pentylenetetrazol induced seizure-like behavior. PLoS One (2011) 0.86
Overexpression of osteopontin, αvβ3 and Pim-1 associated with prognostically important clinicopathologic variables in non-small cell lung cancer. PLoS One (2012) 0.85
The expression of ADAM23 and its correlation with promoter methylation in non-small-cell lung carcinoma. Int J Exp Pathol (2011) 0.82
Epigenetic clustering of gastric carcinomas based on DNA methylation profiles at the precancerous stage: its correlation with tumor aggressiveness and patient outcome. Carcinogenesis (2015) 0.81
Epigenomics in cancer management. Cancer Manag Res (2010) 0.81
Spontaneous reversion of the angiogenic phenotype to a nonangiogenic and dormant state in human tumors. Mol Cancer Res (2014) 0.77
Integrin genetic variants and stage-specific tumor recurrence in patients with stage II and III colon cancer. Pharmacogenomics J (2014) 0.77
c-Abl Kinase Is a Regulator of αvβ3 Integrin Mediated Melanoma A375 Cell Migration. PLoS One (2013) 0.76
Fine Tuning Cell Migration by a Disintegrin and Metalloproteinases. Mediators Inflamm (2017) 0.75
Differential Expression of ADAM23, CDKN2A (P16), MMP14 and VIM Associated with Giant Cell Tumor of Bone. J Cancer (2015) 0.75
ADAM23 is downregulated in side population and suppresses lung metastasis of lung carcinoma cells. Cancer Sci (2016) 0.75
Long-range heterogeneity at the 3' ends of human mRNAs. Genome Res (2002) 3.91
High-throughput SELEX SAGE method for quantitative modeling of transcription-factor binding sites. Nat Biotechnol (2002) 3.04
Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome. Mod Pathol (2008) 2.66
Swine and poultry pathogens: the complete genome sequences of two strains of Mycoplasma hyopneumoniae and a strain of Mycoplasma synoviae. J Bacteriol (2005) 2.15
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic Acids Res (2008) 2.14
Antisense intronic non-coding RNA levels correlate to the degree of tumor differentiation in prostate cancer. Oncogene (2004) 2.02
Nineteen additional unpredicted transcripts from human chromosome 21. Genomics (2002) 1.80
The generation and utilization of a cancer-oriented representation of the human transcriptome by using expressed sequence tags. Proc Natl Acad Sci U S A (2003) 1.79
Approaching a complete repository of sequence-verified protein-encoding clones for Saccharomyces cerevisiae. Genome Res (2007) 1.75
Modeling gene expression regulatory networks with the sparse vector autoregressive model. BMC Syst Biol (2007) 1.69
Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett (2009) 1.60
Maternal embryonic leucine zipper kinase transcript abundance correlates with malignancy grade in human astrocytomas. Int J Cancer (2008) 1.54
Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck, and thyroid cancer. Cancer Res (2005) 1.47
Craniopharyngiomas: intratumoral chemotherapy with interferon-alpha: a multicenter preliminary study with 60 cases. Neurosurg Focus (2010) 1.44
Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human health. Antioxid Redox Signal (2013) 1.43
Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. J Biol Chem (2008) 1.40
High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients. Clin Cancer Res (2007) 1.30
Aberrant promoter methylation of multiple genes during pathogenesis of bladder cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.30
Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential. BMC Cancer (2009) 1.29
TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells. BMC Cancer (2012) 1.27
Sense-antisense pairs in mammals: functional and evolutionary considerations. Genome Biol (2007) 1.26
The impact of SNPs on the interpretation of SAGE and MPSS experimental data. Nucleic Acids Res (2004) 1.19
GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker. Clinics (Sao Paulo) (2011) 1.19
MT1G hypermethylation is associated with higher tumor stage in prostate cancer. Cancer Epidemiol Biomarkers Prev (2005) 1.18
Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity. Am J Pathol (2006) 1.14
Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia (2009) 1.14
Routine drainage after thyroid surgery--a meta-analysis. J Surg Oncol (2007) 1.13
Colorectal cancer "methylator phenotype": fact or artifact? Neoplasia (2005) 1.13
An epigenetic marker panel for detection of lung cancer using cell-free serum DNA. Clin Cancer Res (2011) 1.13
Random X inactivation and extensive mosaicism in human placenta revealed by analysis of allele-specific gene expression along the X chromosome. PLoS One (2010) 1.11
Epigenetic heterogeneity of high-grade prostatic intraepithelial neoplasia: clues for clonal progression in prostate carcinogenesis. Mol Cancer Res (2006) 1.09
Gene copy-number polymorphism caused by retrotransposition in humans. PLoS Genet (2013) 1.09
Beneficial effects of prolactin and laminin on human pancreatic islet-cell cultures. Mol Cell Endocrinol (2006) 1.08
Generation of longer 3' cDNA fragments from massively parallel signature sequencing tags. Nucleic Acids Res (2004) 1.07
Androgen responsive intronic non-coding RNAs. BMC Biol (2007) 1.07
MYC is activated by USP2a-mediated modulation of microRNAs in prostate cancer. Cancer Discov (2012) 1.07
Melanocyte transformation associated with substrate adhesion impediment. Neoplasia (2006) 1.06
Methylation profile of genes CDKN2A (p14 and p16), DAPK1, CDH1, and ADAM23 in head and neck cancer. Cancer Genet Cytogenet (2007) 1.05
Emerging technologies in extracellular vesicle-based molecular diagnostics. Expert Rev Mol Diagn (2014) 1.04
Program for prostate cancer screening using a mobile unit: results from Brazil. Urology (2010) 1.02
Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors. Oncogene (2004) 1.02
Systematic detection of putative tumor suppressor genes through the combined use of exome and transcriptome sequencing. Genome Biol (2010) 1.01
Transient inflammatory response induced by apoptotic cells is an important mediator of melanoma cell engraftment and growth. Int J Cancer (2005) 1.01
Platelet-activating factor receptor (PAF-R)-dependent pathways control tumour growth and tumour response to chemotherapy. BMC Cancer (2010) 1.00
Proteomic and SAGE profiling of murine melanoma progression indicates the reduction of proteins responsible for ROS degradation. Proteomics (2006) 1.00
Arg72Pro TP53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. Int J Cancer (2010) 1.00
Identification of novel differentially expressed genes in human astrocytomas by cDNA representational difference analysis. Brain Res Mol Brain Res (2005) 0.99
A functional SNP in the promoter region of TCOF1 is associated with reduced gene expression and YY1 DNA-protein interaction. Gene (2005) 0.99
Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions. Breast Cancer Res Treat (2007) 0.99
Altered expression of galectin-3 induces cortical thymocyte depletion and premature exit of immature thymocytes during Trypanosoma cruzi infection. Am J Pathol (2007) 0.99
Cisplatin and etoposide in childhood germ cell tumor: brazilian pediatric oncology society protocol GCT-91. J Clin Oncol (2009) 0.97
Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma. Mediators Inflamm (2012) 0.97
Proteomic analysis of low- to high-grade astrocytomas reveals an alteration of the expression level of raf kinase inhibitor protein and nucleophosmin. Proteomics (2010) 0.97
SATR-1 hypomethylation is a common and early event in breast cancer. Cancer Genet Cytogenet (2006) 0.96
Simultaneous CXCL12 and ESR1 CpG island hypermethylation correlates with poor prognosis in sporadic breast cancer. BMC Cancer (2010) 0.96
Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles. Thromb Haemost (2011) 0.93
Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer. PLoS One (2011) 0.93
Comparison of clinical and pathologic findings of prostate cancers detected through screening versus conventional referral in Brazil. Clin Genitourin Cancer (2011) 0.93
ADAM33 gene silencing by promoter hypermethylation as a molecular marker in breast invasive lobular carcinoma. BMC Cancer (2009) 0.93
Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions. DNA Cell Biol (2005) 0.93
Tissue distribution of quiescin Q6/sulfhydryl oxidase (QSOX) in developing mouse. J Mol Histol (2007) 0.92
Lack of galectin-3 alters the balance of innate immune cytokines and confers resistance to Rhodococcus equi infection. Eur J Immunol (2008) 0.92
Toll-like receptor 4 (TLR4) expression in human and murine pancreatic beta-cells affects cell viability and insulin homeostasis. BMC Immunol (2011) 0.92
Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma. Cancer Chemother Pharmacol (2009) 0.91
XPC polymorphisms play a role in tissue-specific carcinogenesis: a meta-analysis. Eur J Hum Genet (2008) 0.91
European ancestry and polymorphisms in DNA repair genes modify the risk of melanoma: a case-control study in a high UV index region in Brazil. J Dermatol Sci (2011) 0.91
Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer. BMC Cancer (2008) 0.90
Genetic diversity of Leishmania amazonensis strains isolated in northeastern Brazil as revealed by DNA sequencing, PCR-based analyses and molecular karyotyping. Kinetoplastid Biol Dis (2007) 0.90
Insights into gliomagenesis: systems biology unravels key pathways. Genome Med (2009) 0.90
Reduced transcription of TCOF1 in adult cells of Treacher Collins syndrome patients. BMC Med Genet (2009) 0.90
Predictive factors for complications in elderly patients who underwent head and neck oncologic surgery. Head Neck (2008) 0.89
A transcript finishing initiative for closing gaps in the human transcriptome. Genome Res (2004) 0.89
Galectin-3 regulates peritoneal B1-cell differentiation into plasma cells. Glycobiology (2009) 0.89
Aberrant methylation in pediatric myelodysplastic syndrome. Leuk Res (2006) 0.88
Differential proteomic analysis of noncardia gastric cancer from individuals of northern Brazil. PLoS One (2012) 0.88
Distinct patterns of somatic alterations in a lymphoblastoid and a tumor genome derived from the same individual. Nucleic Acids Res (2011) 0.88
Redox control of 20S proteasome gating. Antioxid Redox Signal (2012) 0.88
GEDI: a user-friendly toolbox for analysis of large-scale gene expression data. BMC Bioinformatics (2007) 0.88
TGFbetaR2 aberrant methylation is a potential prognostic marker and therapeutic target in multiple myeloma. Int J Cancer (2009) 0.87
Lack of galectin-3 drives response to Paracoccidioides brasiliensis toward a Th2-biased immunity. PLoS One (2009) 0.87
Aminoacetone, a putative endogenous source of methylglyoxal, causes oxidative stress and death to insulin-producing RINm5f cells. Chem Res Toxicol (2008) 0.87
Amyloidogenicity and cytotoxicity of recombinant mature human islet amyloid polypeptide (rhIAPP). J Biol Chem (2004) 0.87
Characterization of a cancer/testis (CT) antigen gene family capable of eliciting humoral response in cancer patients. Proc Natl Acad Sci U S A (2006) 0.87
Feasibility of supraomohyoid neck dissection in N1 and N2a oral cancer patients. Head Neck (2002) 0.86
Epigenetic reprogramming as a key contributor to melanocyte malignant transformation. Epigenetics (2011) 0.86
Clinical implication of 14-3-3 epsilon expression in gastric cancer. World J Gastroenterol (2012) 0.86
Molecular profiling of isolated histological components of wilms tumor implicates a common role for the Wnt signaling pathway in kidney and tumor development. Oncology (2008) 0.86
Galectin-3 negatively regulates the frequency and function of CD4(+) CD25(+) Foxp3(+) regulatory T cells and influences the course of Leishmania major infection. Eur J Immunol (2013) 0.86